Next Article in Journal
Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer
Next Article in Special Issue
Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871
Previous Article in Journal
Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics
Previous Article in Special Issue
Identification of the Neurokinin-1 Receptor as Targetable Stratification Factor for Drug Repurposing in Pancreatic Cancer
 
 
Article

Article Versions Notes

Cancers 2021, 13(15), 3871; https://doi.org/10.3390/cancers13153871 (registering DOI)
Action Date Notes Link
article xml file uploaded 31 July 2021 13:29 CEST Original file -
article xml uploaded. 31 July 2021 13:29 CEST Update -
article pdf uploaded. 31 July 2021 13:29 CEST Version of Record https://www.mdpi.com/2072-6694/13/15/3871/pdf-vor
article html file updated 31 July 2021 13:31 CEST Original file -
Erratum published 15 October 2021 00:00 CEST Erratum https://www.mdpi.com/2072-6694/13/20/5178
article pdf uploaded. 15 October 2021 14:23 CEST Updated version of record https://www.mdpi.com/2072-6694/13/15/3871/pdf
article xml uploaded. 15 October 2021 14:23 CEST Update -
article xml uploaded. 15 October 2021 14:23 CEST Update https://www.mdpi.com/2072-6694/13/15/3871/xml
article html file updated 15 October 2021 14:25 CEST Update -
article html file updated 27 July 2022 07:40 CEST Update https://www.mdpi.com/2072-6694/13/15/3871/html
Back to TopTop